Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy

Health Canada has updated the product information for the Pfizer-BioNTech COVID-19 vaccine to describe very rare reports of Bell’s Palsy (typically temporary weakness or paralysis on one side of the face) following vaccination.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Santé Canada met à jour l'étiquette du vaccin contre la COVID-19 de Pfizer-BioNTech pour mentionner les très rares signalements de paralysie de Bell
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-08-06 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["COVID-19", "étiquette du vaccin COVID-19", "mises à jour du vaccin Pfizer-BioNTech", "Bell's Palsy", "rapports rares", "vaccins COVID-19", "vaccin sûr et efficace"], "en": ["COVID-19", "COVID-19 vaccine label", "updates Pfizer-BioNTech vaccine", "Bell's Palsy", "rare reports", "COVID-19 vaccines", "safe and effective vaccine"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source